Biotech Pioneer Submits Regulation A+ Filing With For Up To $50 Million Initial Public Offering Post author:Sam Post published:September 6, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Aeglea BioTherapeutics Updates Phase I/II Trial Data March 12, 2018 After Merck & Co. & Eli Lilly Alzheimer???s Failures, A Look at 7 Companies Still on the Hunt February 16, 2017 On a Roll: Magenta Therapeutics Nabs Another $50 Million, a Drug From Novartis AG and Deal With May 1, 2017
After Merck & Co. & Eli Lilly Alzheimer???s Failures, A Look at 7 Companies Still on the Hunt February 16, 2017
On a Roll: Magenta Therapeutics Nabs Another $50 Million, a Drug From Novartis AG and Deal With May 1, 2017